XT
CLRB icon

XTX Topco’s Cellectar Biosciences CLRB Stock Holding History

XTX Topco’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,243
Closed -$36.1K – 3897
2025
Q4 		$36.1K Buy
+12,243
New +$45.2K ﹤0.01% 2913
2025
Q2 		– Sell
-3,477
Closed -$32.9K – 2457
2025
Q1 		$32.9K Buy
3,477
+1,914
+122% +$17.3K ﹤0.01% 2056
2024
Q4 		$14K Sell
1,563
-204
-12% -$9.43K ﹤0.01% 2101
2024
Q3 		$113K Sell
1,767
-343
-16% -$22.6K 0.01% 1586
2024
Q2 		$158K Buy
2,110
+1,714
+433% +$164K 0.01% 1317
2024
Q1 		$47.3K Buy
+396
New +$42.9K 0.01% 1481

Other funds holding CLRB

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's CLRB Position: Q1 2026 in Review

XTX Topco sold out of Cellectar Biosciences (CLRB) in Q1 2026, closing a stake of 12,243 shares — an estimated $36.1K sold.

XTX Topco first reported a position in CLRB in Q1 2024 and held it in 6 quarters. The position peaked at $158K in Q2 2024. 19 funds tracked by Wall St. Rank hold CLRB as of Q1 2026.

  • XTX Topco reported no remaining Cellectar Biosciences position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 12,243 Cellectar Biosciences shares in Q1 2026, an estimated $36.1K.
  • XTX Topco first reported a position in Cellectar Biosciences in Q1 2024 and held it in 6 quarters.
  • XTX Topco's Cellectar Biosciences position peaked at $158K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.